Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor

By afschroeder • July 15, 2026

Charles-Schoeman C, Oelke K, Zueger PM, Peng Y, Markley G, Thielen R, Fang S, Bergman M. Long-term Comparative Adherence and Switch Rates in Patients Receiving Advanced Therapies for Rheumatoid Arthritis After Use of One TNF Inhibitor. Rheumatol Ther. 2026 Jul 14. doi: 10.1007/s40744-026-00872-z. Epub ahead of print. PMID: 42446813.

Tags: Adherence, JAK inhibitor, Persistence; Real-world evidence, Publications, Rheumatoid arthritis, Rheumatology, tnf inhibitor, treatment sequencing, Upadacitinib

Nuclear mechanobiology: a brief history and five unresolved questions

Lammerding J, Eeftens J, Gundersen GG, King MC, Lele TP, Li S, Luxton G W G, Medalia O, Piel M, Roca-Cusachs P, Renkawitz J, Roux[...]

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE

Rugo HS, Tolaney SM, Chan N, Borges G, Yerushalmi R, Sharifi MN, McHayleh W, Beck T, Vidula N, Hamilton E, Rinn KJ, O'Shaughnessy J, Curigliano[...]